Baxter International (FRA:BTL) Total Liabilities : €18,164 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Baxter International Total Liabilities?

Baxter International's Total Liabilities for the quarter that ended in Dec. 2023 was €18,164 Mil.

Baxter International's quarterly Total Liabilities increased from Jun. 2023 (€20,540.44 Mil) to Sep. 2023 (€21,073.13 Mil) but then declined from Sep. 2023 (€21,073.13 Mil) to Dec. 2023 (€18,163.94 Mil).

Baxter International's annual Total Liabilities declined from Dec. 2021 (€21,594.00 Mil) to Dec. 2022 (€21,138.05 Mil) and declined from Dec. 2022 (€21,138.05 Mil) to Dec. 2023 (€18,163.94 Mil).

Baxter International Total Liabilities Historical Data

The historical data trend for Baxter International's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baxter International Total Liabilities Chart

Baxter International Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

9,252.90

9,282.85

21,594.00

21,138.05

18,163.94

Baxter International Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Liabilities	Get a 7-Day Free Trial															21,138.05	20,874.90	20,540.44	21,073.13	18,163.94

Baxter International Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Baxter International's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	5963.251	+	(10607.856	+	298.025
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	452.081	+	842.723)
	=	18,164

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	25929.092	-	7765.156
	=	18,164

Baxter International's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	5963.251	+	(10607.856	+	298.025
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	452.081	+	842.723)
	=	18,164

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	25929.092	-	7765.156
	=	18,164

Baxter International Total Liabilities Related Terms

Thank you for viewing the detailed overview of Baxter International's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Baxter International (FRA:BTL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Baxter International Inc (FRA:BTL) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

BAX:USA 1BAX:Italy BAX:Austria

Address

One Baxter Parkway, Deerfield, IL, USA, 60015

Website

https://www.baxter.com

Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment, including hospital beds, to the portfolio, although about half of Hillrom's revenue comes from more digitally connected offerings like its smart beds and Voalte medical communications app. From its legacy operations, Baxter offers tools to help patients with acute and chronic kidney failure, which it plans to spin off by mid-2024. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents.

Baxter International (FRA:BTL) Headlines

No Headlines